We are RECRUITING ! Interested in a Senior Director, Business Development position ? Apply now !

News & Events

ABOUT CQDM CQDM is a meeting ground for all stakeholders in biopharmaceutical research. Its principal mission is to fund research projects carried out in partnership between the academic and private sectors. An innovative Canadian initiative, CQDM has two major goals: to accelerate the drug discovery process and to develop safer and more effective drugs. CQDM is funded through contributions from … Read More

Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics

News & Events

Amgen and Takeda join the Quantum Leap project led by CQDM and Feldan Therapeutics, to improve a novel intracellular delivery technology Philadelphia, June 4th, 2019 – CQDM is pleased to announce that following their recent enrollment in the consortium, Amgen and Takeda will be joining the syndicate of pharma companies to fund the Quantum Leap project recently launched by Feldan … Read More

Contribution from the MEI ($3.3M) allows CQDM to support 5 biopharmaceutical research projects ($15.5M)

News & Events

These highly innovative technologies will address unmet medical needs in cancer and diabetes Philadelphia, June 4th, 2019 – Thanks to a C$3.3M contribution from the MEI, and the participation of several partners, CQDM is proud to announce the funding of five collaborative research projects totaling C$15.5M. Headed by world-class experts in the field of cancer and diabetes, these projects include cutting-edge disciplines … Read More

The CCS, CQDM and biotech companies will invest nearly $10M to support 3 breast cancer research projects

News & Events

Montreal, June 1, 2019 – The Canadian Cancer Society (CCS), a leading breast cancer research funder, and CQDM, a Quebec research consortium whose mission is to fund the development of biopharmaceutical technologies and drugs, are proud to announce that nearly $10 million will be invested to fund three breast cancer research projects over the next three years. “The research partnership … Read More

CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize

News & Events

CQDM, Diazon and the Oncopole in collaboration with Mitacs announce the two laureates of the 2019 Gordon Shore Prize, a mark of excellence for new graduates in life sciences Montreal, May 22, 2019 – CQDM, Diazon Pharmaceuticals, the Oncopole, and Mitacs, are delighted to announce the two laureates of the 2019 Gordon Shore Prize: Rachel Jodoin and Shilpa Chennakrishnaiah. Created … Read More

Hope on the horizon for hard-to-treat breast cancers

News & Events

Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators Montreal, Canada, May 14, 2019 – The NEOMED Institute (NEOMED), CQDM, the Canadian Cancer Society (CCS), the Goodman Cancer Research Centre (GCRC) and the Lady Davis Institute (LDI) announced today a unique multi-party collaboration to develop new anti-cancer therapies. This collaboration is intended to more rapidly advance two … Read More

CQDM, HBHL, Corbin Therapeutics and Brain Canada award $1.5 M to McGill Prof. Philippe Gros

News & Events

Montreal, May 2nd, 2019 – CQDM is pleased to announce that Professor Philippe Gros from McGill University has been awarded $1.5 million as part of the SynergiQC program to pursue the development and validation of new inhibitors of ubiquitin-specific protein protease (USP-15) and its partner TRIM25, that plays a key role in neuroinflammation-based disorders. From this development, Dr. Gros aims to … Read More

We are RECRUITING! Interested in a Project Coordinator position? Apply now!

News & Events

À PROPOS DU CQDM Le CQDM est un consortium de recherche biopharmaceutique fondé en 2008 qui a pour mission de financer le développement de technologies novatrices destinées à accélérer la découverte et la mise au point de médicaments. Notre modèle d’affaires privilégie une approche collaborative où les grandes entreprises pharmaceutiques mondiales, les sociétés de biotechnologie canadiennes, ainsi que les gouvernements … Read More

We are RECRUITING! Interested in a Artificial Intelligence Project Manager position? Apply now!

News & Events

About CQDM CQDM is a biopharma-based research consortium created in 2008 with the mission to fund the development of innovative technologies to accelerate the drug discovery and development. Its business model is based on a collaborative approach bringing together world-leading pharmaceutical organizations, Canadian biotech companies as well as the Canadian and Quebec governments who share the costs of the research. … Read More

IMV and CRCHU de Québec-U Laval Collaboration Awarded a CQDM Grant to Develop First-in-class Dual Target T cell Therapy in Bladder Cancer Based on IMV’s DPX Technology

News & Events

Two antigens are targeted in combination with the DPX technology developed by IMV Quebec City, Quebec, March 18, 2019 – IMV Inc. (IMV) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Canadian bioresearch consortium CQDM has awarded a grant to a collaboration among IMV, Centre de recherche du CHU de Québec-Université Laval, and La Fondation du … Read More